DT
HealthMore in Health→
Low-Dose Digoxin Misses Primary Goal but Hints at Fewer Heart Failure Events
Key Takeaways
- The DECISION trial randomized 1,001 heart failure patients to low-dose digoxin or placebo.
- The primary composite outcome was not significantly reduced in the digoxin group.
- Worsening heart failure events were numerically lower with digoxin, suggesting a possible signal short of statistical significance.
DE
DT Editorial Team··via nature.com